CN102000238A - Martianus dermestoides capsule and preparation method - Google Patents
Martianus dermestoides capsule and preparation method Download PDFInfo
- Publication number
- CN102000238A CN102000238A CN200910013578XA CN200910013578A CN102000238A CN 102000238 A CN102000238 A CN 102000238A CN 200910013578X A CN200910013578X A CN 200910013578XA CN 200910013578 A CN200910013578 A CN 200910013578A CN 102000238 A CN102000238 A CN 102000238A
- Authority
- CN
- China
- Prior art keywords
- parts
- capsule
- radix
- kowloon
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241000220350 Ulomoides dermestoides Species 0.000 title abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 42
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 230000036039 immunity Effects 0.000 claims abstract description 8
- 238000012216 screening Methods 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 3
- 241000190633 Cordyceps Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 235000005903 Dioscorea Nutrition 0.000 claims description 5
- 241000234273 Dioscorea Species 0.000 claims description 5
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 235000004879 dioscorea Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 7
- 206010030113 Oedema Diseases 0.000 abstract description 5
- 201000001881 impotence Diseases 0.000 abstract description 5
- 230000035807 sensation Effects 0.000 abstract description 5
- 206010000087 Abdominal pain upper Diseases 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 206010036596 premature ejaculation Diseases 0.000 abstract description 2
- 206010034568 Peripheral coldness Diseases 0.000 abstract 2
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 206010008531 Chills Diseases 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 210000002683 foot Anatomy 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 8
- 208000019790 abdominal distention Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 5
- 230000013872 defecation Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010067171 Regurgitation Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940104825 bismuth aluminate Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 102000005606 Activins Human genes 0.000 description 2
- 108010059616 Activins Proteins 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- -1 bismuth aluminate compound Chemical class 0.000 description 2
- 208000021735 chronic enteritis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000008929 jingui shenqi Substances 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- PDSAKIXGSONUIX-UHFFFAOYSA-N hexaaluminum;dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Bi+3].[Bi+3] PDSAKIXGSONUIX-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a martianus dermestoides capsule for adjusting and treating the sub-health and improving the immunity and a preparation method thereof. The martianus dermestoides capsule comprises the following pharmaceutical ingredients in ratio by weight: 20-40 parts of martianus dermestoides, 1-5 parts of cordyceps sinensis, 5-20 parts of American ginseng, 30-50 parts of astragalus, 20-30 parts of poria cocos, 20-30 parts of Chinese yam, 10-20 parts of angelica, 10-20 parts of rehmanniae vaporata, 10-20 parts of atractylodes, 10-20 parts of tangerine peel, and 10-20 parts of glycyrrhiza. The preparation method comprises the steps of: screening the pharmaceutical ingredients, drying, crushing, sterilizing at high temperature, and putting in a capsule. The martianus dermestoides capsule of the invention ensures that the patient can defecate and fart more, has gastrointestinal comfort, spiritedness and refreshment, and brings favorable effect to stomachache, abdominal distension, constipation, edema, impotence and premature ejaculation, sensation of chill, and cold hands and feet and the like; therefore, the martianus dermestoides capsule is an ideal drug and health care product capable of rapidly changing sub-health, improving the immunity, activating the helpful cells in human body and improving various bad symptoms.
Description
Technical field
The present invention relates to the medicine of a kind of adjusting, treatment subhealth state, raising body immunity.Be to be the Chinese medicine composition that raw material is made into the Chinese herbal medicine specifically.Can improve function of human body, replenish body energy.The invention still further relates to the preparation method of this medicine.
Background technology
, stress fast for modern society's rhythm of life is big, the ubiquity sub-health state.Especially person in middle and old age's aging phenomenon progressively presents: waist soreness, tinnitus, eyes are dry and astringent, dysfunction of spleen and stomach, gastrointestinal function disorder.People adopt the conventional therapy of Western medicine usually, and which painful doctor where, cures the symptoms, not the disease.Nowadays people's sight turns to Chinese medicine, seeks to regulate physical function with Chinese medicine, improves the medicine of body immunity, slow down aging, change sub-health state.
Summary of the invention
The objective of the invention is at subhealth state and mid-aged population, a kind of human body immunity improving power is provided, replenishes body energy, Yin Yang balancing, treating both the principal and secondary aspects of a disease.The medicine that i.e. health care is treated again and the preparation method of medicine thereof.
The present invention provides this gold dragon capsule crude drug by weight ratio:
Kowloon worm 20-40 part, Cordyceps 1-5 part, Radix Panacis Quinquefolii 5-20 part, Radix Astragali 30-50 part, Poria 20-30 part, Rhizoma Dioscoreae 20-30 part, Radix Angelicae Sinensis 10-15 part, Radix Rehmanniae Preparata 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Pericarpium Citri Reticulatae 10-20 part, Radix Glycyrrhizae 10-20 part etc.
The present invention is to be monarch drug by the Kowloon worm.Kowloon worm kidney invigorating and YANG supporting, warming middle-JIAO is regulated the flow of vital energy and the five internal organs, muscle reinforcing and bone strengthening, dry and search wind, strengthening the spleen and stomach, logical intestinal, replenish body energy.(Kowloon worm original name Martianus dermestoides Chevr., another name Kowloon worm.Be admitted on the books " detailed outline is picked up any lost article from the road " and the property of medicine.)
Cordyceps, Radix Panacis Quinquefolii, the Radix Astragali, Rhizoma Dioscoreae, Poria are the medicine of tonification, to help the efficacy of a drug of golden imperial worm, are ministerial drug.
Chinese angelica blood supplementing is invigorated blood circulation, and Radix Rehmanniae Preparata nourishing YIN and benefiting blood, vital essence replenishing and marrow benifiting are adjuvant drug.
Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening, the Pericarpium Citri Reticulatae regulating QI of the middle-JIAO, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is messenger drug.
All medicines share, QI invigorating, enrich blood, warming middle-JIAO, dehumidifying, kidney invigorating and YANG supporting, adjusting taste, logical intestinal, be health preserving, the good medicine of curing the disease again.
The optimum ratio of raw material of the present invention is:
Kowloon worm 30-40 part, Cordyceps 1-3 part, Radix Panacis Quinquefolii 5-10 part, Radix Astragali 30-40 part, Poria 20-25 part, Rhizoma Dioscoreae 25-30 part, Radix Angelicae Sinensis 10-15 part, Radix Rehmanniae Preparata 15-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Pericarpium Citri Reticulatae 10-20 part, Radix Glycyrrhizae 10-15 part.
Preparation method of the present invention be with crude drug respectively through screening, drying, pulverizing, high temperature sterilize, powdery medicine is encapsulated.
The given medicine of the present invention is after taking, and very fast sensation defecation is many, aerofluxus is many, gastrointestinal is comfortable, spiritedness, a kind of sensation of spirit and QI cleaning is arranged.To stomachache, abdominal distention, constipation, diarrhoea, edema, impotence and premature ejaculation, be afraid of cold, trick cold etc. has good effect.Its determined curative effect, therapeutic effect is good, have no side effect.Be a kind of rapid transformation subhealth state, raising body immunity, the useful cell of human activin.Improve the ideal medicament and the health product of various ill symptomses.
The preparation method of this medicine is simple, is easy to processing, and it is extensive to be suitable for the crowd, is convenient to clinical practice.
The specific embodiment
Implementation column 1
Take by weighing raw material by following weight proportion
30 parts of Kowloon worms, 2 parts of Cordyceps, 10 parts of Radix Panacis Quinquefoliis, 30 parts of the Radixs Astragali, 20 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 15 parts of Radix Angelicae Sinensis, 20 parts in Radix Rehmanniae Preparata, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Pericarpium Citri Reticulataes, 10 parts in Radix Glycyrrhizae.
Preparation method is as follows:
Crude drug respectively through screening, dry, pulverized 120 mesh sieves, high temperature sterilize, powdery medicine is encapsulated.
Implementation column 2
20 parts of Kowloon worms, 1 part of Cordyceps, 5 parts of Radix Panacis Quinquefoliis, 30 parts of the Radixs Astragali, 20 parts in Poria, 20 parts of Rhizoma Dioscoreaes, 10 parts of Radix Angelicae Sinensis, 10 parts in Radix Rehmanniae Preparata, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Pericarpium Citri Reticulataes, 10 parts in Radix Glycyrrhizae.
Preparation method is with embodiment 1.
Embodiment 3
40 parts of Kowloon worms, 5 parts of Cordyceps, 20 parts of Radix Panacis Quinquefoliis, 50 parts of the Radixs Astragali, 30 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 20 parts of Radix Angelicae Sinensis, 20 parts in Radix Rehmanniae Preparata, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Pericarpium Citri Reticulataes, 20 parts in Radix Glycyrrhizae.
Preparation method is with embodiment 1.
Embodiment 4
35 parts of Kowloon worms, 3 parts of Cordyceps, 10 parts of Radix Panacis Quinquefoliis, 40 parts of the Radixs Astragali, 25 parts in Poria, 25 parts of Rhizoma Dioscoreaes, 15 parts of Radix Angelicae Sinensis, 15 parts in Radix Rehmanniae Preparata, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Pericarpium Citri Reticulataes, 15 parts in Radix Glycyrrhizae.
Preparation method is with embodiment 1.
Case
1, Wang: man, 43 years old.Impotence due to deficiency of the kidney, waist soreness, disability.Once run a lot of hospitals but do not have good effect, and taken a lot of Chinese medicines (decoction) again as LIUWEI DIHUANG WAN, curative effect is all undesirable.Take Kowloon of the present invention capsule after one month, complexion is clearly better, and complexion changes ruddy by black.Fat after 2 months, sexual impotence, the soreness of waist, the soft transference cure of lower limb, go out every day and done manual work.
2, Guo: woman, 62 years old.Waking up of stomachache, frequent stomachache at night.Abdominal distention, acid regurgitation, edema of lower limbs.Be diagnosed as superficial gastritis, duodenal ulcer through hospital gastroscope.Take Western medicine such as bismuth aluminate compound, omeprazole and do not have positive effect in one month.Took Kowloon of the present invention capsule afterwards 7 days.Defecation, aerofluxus are many, and the sensation stomach is comfortable.Taking after two months, abdominal distention, acid regurgitation symptom have not had.Stomach is not painful, has had a good complexion.Edema of lower limbs might as well.
3, the week certain: woman, 61 years old.Often diarrhoea.Defecate 3-4 every day.The not molding of defecating.Be diagnosed as chronic enteritis to examination in hospital.Take Western medicine such as berberine, woods mycin calcium, taking Chinese medicine such as SHENLING BAISHU SAN does not all have to cure.Take the Kowloon capsule and just feel after 2 days that belly is comfortable.It is normal to take after one month stool, and stool is shaped.Body weight has also increased.
4, shut out certain: woman, 55 years old.Long-term weakness of the spleen and stomach, flatulence, thick fur is greasy, eyes are dry and astringent, yellowish complexion, weak, take Radix Bupleuri SHUGAN WAN and Chinese herbal medicine (decoction) treatment, effect is all not so good.Taking Kowloon of the present invention capsule had rosy cheeks after one month.Eyes are not dry and astringent.Weak do not had.The mental status is clearly better.
5, Tong: man, 30 years old.Often feel fatigue, easy to catch cold.Find fatty liver during health check-up, sometimes abdominal distention, constipation, played a lot of pimples on the face and on one's body.The prescription on individual diagnosis traditional Chinese medical science is taken decoction and is regulated, and does not obviously improve.Take and just feel that defecation is many, it is salubrious to discharge in one week of Kowloon of the present invention capsule.Take did not have with the pimple of back in one month on the face.Abdominal distention and constipation have all been got well.And hale and hearty, tired sensation has not had.All there is not flu in winter, a spring.
Comparative Examples:
1. the present invention and JINGUI SHENQI WAN contrast
| Group | Clinical number | The course of treatment | Effective percentage |
| JINGUI SHENQI WAN | 10 | 2-4 course of treatment | Cure 5 people, effective 2 people, invalid 3 people, effective percentage is 70%. |
| The Kowloon capsule | 10 | 2-4 course of treatment | Cure 8 people, effective 2 people, invalid 3 people, effective percentage is 100%. |
(two weeks is a course of treatment, and therapeutic dose is the 6-8 gram, and the health care amount is the 4-6 gram)
The present invention successively follows the tracks of to execute and controls, deficiency of kidney-YANG syndrome, and impotence due to deficiency of the kidney, waist soreness, aversion to cold and cold limbs, tinnitus, edema patient's 62 examples are cured 54 examples at medication 2-4 course of treatment, 6 examples that take effect, invalid 1 example, total effective rate is 96.7%.
2. the present invention and bismuth aluminate compound contrast
| Group | Clinical number | The course of treatment | Effective percentage |
| Bismuth aluminate compound | 30 people | 1-2 course of treatment | Cure 18 examples, effective 7 examples, invalid 5 examples, effective percentage is 83%. |
| The Kowloon capsule | 30 people | 1-2 course of treatment | Cure 25 examples, effective 3 examples, invalid 2 examples, effective percentage is 93.3%. |
The present invention successively follows the tracks of Peptic Ulcers, and chronic gastritis, chronic enteritis, abdominal distention acid regurgitation, loss of appetite, yellowish complexion, weak are treated 40 examples, takes and just feels that defecation is many 1 week, aerofluxus is many, and gastrointestinal is comfortable, medication 1-3 course of treatment, cures 35 examples, effective 4 examples, invalid 1 example, total effective rate is 97.5%.
3. the present invention and spirulina contrast
| Group | Clinical number | The course of treatment | Effective percentage |
| Spirulina | 10 people | 1-2 course of treatment | Cure 4 people, effective 4 people, invalid 2 people, effective percentage is 80%. |
| The Kowloon capsule | 10 people | 1-2 course of treatment | Cure 7 people, effective 3 people, effective percentage is 100%. |
Subhealth state is that operating pressure is big, irregular the causing of living because overtired, immunity reduces, and resistance descends, and at first shows easy fatigue, flu, gastrointestinal dysfunction, it is bad to sleep, and the present invention follows the tracks of to execute and controls 52 examples, medication 1-3 course of treatment, 48 examples of getting well, effective 4 examples, effective percentage is 100%.
Numerous users show that the Kowloon capsule can replenish body energy, the useful cell of human activin, and instant effect, good effect is the health product of life lengthening, is again the good medicine that improves the various symptoms of human body.
Claims (6)
1. Chinese medicine composition Kowloon capsule that can improve body immunity, it is characterized in that it is to be made by weight ratio by following raw material medicaments: Kowloon worm 20-40 part, Cordyceps 1-5 part, Radix Panacis Quinquefolii 5-20 part, Radix Astragali 30-50 part, Poria 20-30 part, Rhizoma Dioscoreae 20-30 part, Radix Angelicae Sinensis 10-20 part, Radix Rehmanniae Preparata 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Pericarpium Citri Reticulatae 10-20 part, Radix Glycyrrhizae 10-20 part.
2. according to the described Kowloon of claim 1 capsule, the weight proportion that it is characterized in that each crude drug is: Kowloon worm 30-40 part, Cordyceps 1-3 part, Radix Panacis Quinquefolii 5-10 part, Radix Astragali 30-40 part, Poria 20-25 part, Rhizoma Dioscoreae 25-30 part, Radix Angelicae Sinensis 10-15 part, Radix Rehmanniae Preparata 15-20 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Pericarpium Citri Reticulatae 10-15 part, Radix Glycyrrhizae 10-15 part.
3. according to the described Kowloon of claim 1 capsule, it is characterized in that the weight proportion of various crude drug is: 30 parts of Kowloon worms, 2 parts of Cordyceps, 10 parts of Radix Panacis Quinquefoliis, 30 parts of the Radixs Astragali, 20 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 15 parts of Radix Angelicae Sinensis, 20 parts in Radix Rehmanniae Preparata, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Pericarpium Citri Reticulataes, 10 parts in Radix Glycyrrhizae.
4. according to the imperial capsule of the described gold of claim 1, it is characterized in that to make powder, tablet.
5. Kowloon as claimed in claim 1 capsule preparation method thereof is characterized in that: by the crude drug of said ratio respectively through screening, drying, pulverizing, high temperature sterilize, must powdery medicine encapsulated.
6. by the capsular preparation method in the described Kowloon of claim 5, it is characterized in that: said crude drug pulverized sieved in 120th powdery medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910013578XA CN102000238B (en) | 2009-09-02 | 2009-09-02 | Jiulong capsule and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910013578XA CN102000238B (en) | 2009-09-02 | 2009-09-02 | Jiulong capsule and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102000238A true CN102000238A (en) | 2011-04-06 |
| CN102000238B CN102000238B (en) | 2012-04-18 |
Family
ID=43808107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910013578XA Expired - Fee Related CN102000238B (en) | 2009-09-02 | 2009-09-02 | Jiulong capsule and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102000238B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055131A (en) * | 2011-10-21 | 2013-04-24 | 澳门科技大学 | Medicinal composition for preventing and treating chronic fatigue and preparation method thereof |
| CN105194212A (en) * | 2015-11-09 | 2015-12-30 | 陈慧珊 | Traditional Chinese medicine oral liquid for conditioning sub-health of women and preparation method |
| CN105194211A (en) * | 2015-11-09 | 2015-12-30 | 陈慧珊 | A traditional Chinese medicine oral liquid for alleviating female chronic fatigue syndrome and its preparation method |
| CN108578546A (en) * | 2018-08-07 | 2018-09-28 | 王维武 | A kind of Chinese medicine of conditioning subhealth state |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060069C (en) * | 1996-05-14 | 2001-01-03 | 富国璞 | Body-building liquor |
| CN1201669A (en) * | 1997-06-06 | 1998-12-16 | 东万春 | Chinese medicines for deferring senility and nourishing Yin and checking exuberant |
-
2009
- 2009-09-02 CN CN200910013578XA patent/CN102000238B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055131A (en) * | 2011-10-21 | 2013-04-24 | 澳门科技大学 | Medicinal composition for preventing and treating chronic fatigue and preparation method thereof |
| CN105194212A (en) * | 2015-11-09 | 2015-12-30 | 陈慧珊 | Traditional Chinese medicine oral liquid for conditioning sub-health of women and preparation method |
| CN105194211A (en) * | 2015-11-09 | 2015-12-30 | 陈慧珊 | A traditional Chinese medicine oral liquid for alleviating female chronic fatigue syndrome and its preparation method |
| CN108578546A (en) * | 2018-08-07 | 2018-09-28 | 王维武 | A kind of Chinese medicine of conditioning subhealth state |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102000238B (en) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772770B (en) | Traditional Chinese medicine composition for treating cold-damp affecting spleen syndrome | |
| CN103705843B (en) | A kind of medicine for the treatment of gastropathy | |
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN101502582B (en) | Composition for eliminating stagnation and promoting lactation and preparation method thereof | |
| CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
| CN102772778A (en) | Chinese medicinal composition for treating summer heat-dampness | |
| CN102000238B (en) | Jiulong capsule and its preparation method | |
| CN1541676A (en) | Health care medicine for enriching blood in puerperium and its preparation and uses | |
| CN103301386A (en) | Pill for treating qi failing to consolidate semen and preparation method thereof | |
| CN102908474A (en) | Medicinal liquor for treating neurosis | |
| CN101675983A (en) | Warming and tonifying agent for qi-deficiency syndrome | |
| CN108272986A (en) | A kind of draft is bathed powder | |
| CN102885946A (en) | Chinese medicament for treating cough and asthma | |
| CN102626509B (en) | Traditional Chinese medicine composite for curing pediatric jaundice | |
| CN101406624A (en) | Chinese medicine composing prescription having functions of regulation, auxiliary treatment for various diseases | |
| CN106072556A (en) | For health food regulating blood glucose and preparation method thereof | |
| CN101632831B (en) | Traditional Chinese medicine medicated wine for treating waist and leg pains | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN105194506A (en) | Chinese medicinal composition for treating spleen-qi deficiency type qi goiter | |
| CN110538288A (en) | Intelligent system plaster for conditioning physique and preventing and treating diseases and preparation method thereof | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN104001070A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103656277B (en) | The medicine for the treatment of hepatic ascites | |
| CN102423414B (en) | External Chinese medicinal preparation for treating cold-accumulation and qi-stagnation stomachache | |
| CN102327591B (en) | Phlegm-eliminating pill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20160902 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |